Daré Bioscience, Inc. (DARE)
0.7892
+0.05
(+6.58%)
USD |
NASDAQ |
Sep 25, 16:00
0.7892
0.00 (0.00%)
After-Hours: 19:08
Daré Bioscience Cash from Operations (TTM) : -11.29M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.29M |
| March 31, 2026 | -9.936M |
| December 31, 2025 | -9.886M |
| September 30, 2025 | -17.25M |
| June 30, 2025 | -3.900M |
| March 31, 2025 | -5.303M |
| September 30, 2024 | -8.011M |
| June 30, 2024 | -10.06M |
| March 31, 2024 | -29.56M |
| December 31, 2023 | -38.86M |
| September 30, 2023 | -36.57M |
| June 30, 2023 | -20.00M |
| March 31, 2023 | -21.86M |
| December 31, 2022 | -18.09M |
| September 30, 2022 | -22.11M |
| June 30, 2022 | -29.39M |
| March 31, 2022 | -32.73M |
| December 31, 2021 | -28.76M |
| September 30, 2021 | -28.04M |
| June 30, 2021 | -34.72M |
| March 31, 2021 | -27.01M |
| December 31, 2020 | -25.23M |
| September 30, 2020 | -19.85M |
| June 30, 2020 | -17.67M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.60M |
| December 31, 2019 | -13.32M |
| September 30, 2019 | -12.22M |
| June 30, 2019 | -11.79M |
| March 31, 2019 | -11.46M |
| December 31, 2018 | -10.27M |
| September 30, 2018 | -8.519M |
| June 30, 2018 | -7.188M |
| March 31, 2018 | -4.608M |
| December 31, 2017 | -2.540M |
| September 30, 2017 | -3.454M |
| June 30, 2017 | -9.195M |
| March 31, 2017 | -20.33M |
| December 31, 2016 | -33.54M |
| September 30, 2016 | -39.87M |
| June 30, 2016 | -40.68M |
| March 31, 2016 | -37.23M |
| December 31, 2015 | -31.92M |
| September 30, 2015 | -29.31M |
| June 30, 2015 | -26.90M |
| March 31, 2015 | -23.34M |
| December 31, 2014 | -19.06M |
| September 30, 2014 | -16.72M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Nektar Therapeutics | -233.79M |
| Elite Pharmaceuticals, Inc. | 19.04M |
| Eton Pharmaceuticals, Inc. | 15.14M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |